Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | 15 Oct 2025 | 6,800,000 | 8,377,952 | - | - | Class A Common Stock | ||
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | 15 Oct 2025 | 6,800,000 | 8,377,952 | - | - | Class A Common Stock | ||
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | 15 Oct 2025 | 6,800,000 | 1,351,882,620 | - | - | UWM Paired Interests | ||
| AvePoint Inc (Class A) | Tianyi Jiang | Director, Chief Executive Officer | Other type of transaction at price $ 14.61 per share. | 15 Oct 2025 | 1,542,779 | 1,657,459 | - | 14.6 | 22,540,001 | Common Stock |
| AvePoint Inc (Class A) | Tianyi Jiang | Director, Chief Executive Officer | Other type of transaction at price $ 14.61 per share. | 15 Oct 2025 | 1,542,779 | 15,384,632 | - | 14.6 | 22,540,001 | Common Stock |
| Vivani Medical Inc | Gregg G. Williams | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 15 Oct 2025 | 1,473,214 | 17,382,562 | - | 1.1 | 1,650,000 | Common Stock |
| Nerdy Inc (Class A) | John A. Paszterko | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 1.11 per share. | 15 Oct 2025 | 600,000 | 600,000 | - | 1.1 | 666,000 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 15 Oct 2025 | 596,356 | 7,185,240 | - | 5.3 | 3,136,833 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 15 Oct 2025 | 596,356 | 7,781,596 | - | 5.4 | 3,214,359 | Class A Common Stock |
| SentinelOne Inc (Class A) | Ana G. Pinczuk | Director, President Product & Technology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 501,938 | 572,489 | - | 0 | Class A Common Stock | |
| Franklin Resources Inc | Daniel E. Gamba | Co-President, Chief Commercial | Grant, award, or other acquisition of securities at price $ 22.79 per share. | 15 Oct 2025 | 442,870 | 442,870 (0%) | 0% | 22.8 | 10,093,007 | Common Stock, par value $.10 |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.85 per share. | 15 Oct 2025 | 414,683 | 1,919,642 | - | 15.9 | 6,572,726 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 414,683 | 436,700 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 16.93 per share. | 15 Oct 2025 | 414,683 | 1,504,959 | - | 16.9 | 7,020,583 | Common Shares |
| Grindr Inc (Class A) | James Fu Bin Lu | Director, Ten Percent Owner | 15 Oct 2025 | 400,000 | 24,138,867 | - | 12.7 | 5,064,000 | Common Stock | |
| Grindr Inc (Class A) | James Fu Bin Lu | Director, Ten Percent Owner | 15 Oct 2025 | 400,000 | 24,538,867 | - | 13.0 | 5,184,000 | Common Stock | |
| Bit Digital Inc | Erke Huang | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 325,000 | 325,000 | - | - | Restricted Stock Units | |
| Bit Digital Inc | Erke Huang | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 325,000 | 2,675,000 (18%) | 2% | - | Ordinary Shares, $.01 par value | |
| Bit Digital Inc | Samir Tabar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 325,000 | 325,000 | - | - | Restricted Stock Units | |
| Bit Digital Inc | Samir Tabar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 325,000 | 2,988,089 (20%) | 2% | - | Ordinary Shares, $.01 par value | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 318,282 | 118,418 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 15 Oct 2025 | 318,282 | 1,504,959 | - | 17.0 | 5,426,708 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.85 per share. | 15 Oct 2025 | 318,282 | 1,823,241 | - | 15.9 | 5,044,770 | Common Shares |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 313,126 | 1,414,654 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 313,126 | 3,131,263 | - | - | Restricted Stock Units (RSU) | |
| Sweetgreen Inc (Class A) | Jamie McConnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Vivani Medical Inc | Gregg G. Williams | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 15 Oct 2025 | 264,550 | 17,647,112 | - | 1.3 | 333,333 | Common Stock |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 258,981 | 117,719 | - | - | Restricted Stock Units | |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 258,981 | 558,981 | - | 0 | Common Stock | |
| Clover Health Investments Corp (Class A) | Andrew Toy | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 242,580 | 9,922,982 | - | 2.8 | 679,224 | Class A Common Stock |
| Xenon Pharma Inc | Thomas P. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 225,000 | 225,000 | - | - | Share Option (Right to Buy) | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 200,000 | 4,966,425 | - | - | ADK Class A Units | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 200,000 | 335,602 | - | 0 | Class A Common Stock | |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.01 per share. | 15 Oct 2025 | 200,000 | 135,602 | - | 6.0 | 1,201,320 | Class A Common Stock |
| Indie Semiconductor Inc (Class A) | Donald McClymont | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 200,000 | 4,966,425 | - | 0 | Class V Common Stock | |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share. | 15 Oct 2025 | 200,000 | 300,000 | - | 1.2 | 232,000 | Common Stock |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Grindr Inc (Class A) | George Arison | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.74 per share. | 15 Oct 2025 | 190,425 | 1,878,471 | - | 12.7 | 2,426,015 | Common Stock |
| Ribbon Communications Inc | Shaul Shani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 185,210 | 185,210 | - | - | Restricted Stock Units (RSUs) | |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 178,572 | 1,432,532 | - | 0 | Class A Common Stock | ||
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 178,572 | 892,857 | - | - | Restricted Stock Units (RSU) | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 15 Oct 2025 | 154,479 | 154,479 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 15 Oct 2025 | 154,479 | 5,557,521 | - | - | Class B Common Stock | ||
| Sweetgreen Inc (Class A) | Jamie McConnell | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 150,000 | 150,000 | - | 0 | Class A Common Stock | |
| Cheetah Net Supply Chain Service Inc (Class A) | Huan Liu | Director, See Remarks, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 144,000 | 175,250 | - | 0 | Class B Common Stock | |
| Soluna Holdings Inc | Agnieszka Teresa Budzyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 135,000 | 135,000 | - | 0 | Common Stock | |
| Ribbon Communications Inc | John Townsend | EVP, Chief Financial Officer | 15 Oct 2025 | 128,205 | 128,205 (0%) | 0% | - | Common Stock | ||
| Ribbon Communications Inc | John Townsend | EVP, Chief Financial Officer | 15 Oct 2025 | 128,205 | 102,564 | - | - | Restricted Stock Units (RSUs) | ||
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 123,216 | 1,291,438 | - | 2.1 | 257,521 | Class A Common Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.92 per share. | 15 Oct 2025 | 122,734 | 122,734 | - | 16.9 | 2,077,212 | Class A Common Stock |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Sale of securities on an exchange or to another person at price $ 17.06 per share. | 15 Oct 2025 | 118,418 | 1,504,959 | - | 17.1 | 2,020,211 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 118,418 | 0 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Eric Venker | President & Immunovant CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.85 per share. | 15 Oct 2025 | 118,418 | 1,623,377 | - | 15.8 | 1,876,925 | Common Shares |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 114,285 | 198,331 (0%) | 0% | 0 | Common Stock | |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Ten Percent Owner | 15 Oct 2025 | 108,600 | 108,600 | - | 0 | Class A Common Stock | ||
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Ten Percent Owner | 15 Oct 2025 | 108,600 | 15,833,872 | - | - | Class B Common Stock | ||
| Sera Prognostics Inc (Class A) | Tiffany Eul Davis Inglis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 107,000 | 107,000 | - | - | Stock Option (right to buy) | |
| Phoenix Education Partners Inc | Martin H. Nesbitt | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.92 per share. | 15 Oct 2025 | 105,452 | 4,935,463 | - | 29.9 | 3,155,124 | Common Stock |
| Phoenix Education Partners Inc | Adnan A. Nisar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.92 per share. | 15 Oct 2025 | 105,452 | 4,935,463 | - | 29.9 | 3,155,124 | Common Stock |
| Gevo Inc | Christopher Ryan | President & COO | Sale of securities on an exchange or to another person at price $ 2.82 per share. | 15 Oct 2025 | 100,000 | 1,531,938 (10%) | 0% | 2.8 | 281,870 | Common Stock |
| GrabAGun Digital Holdings Inc | Marc Nemati | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.89 per share. | 15 Oct 2025 | 100,000 | 120,000 | - | 3.9 | 388,770 | Common Stock |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.67 per share. | 15 Oct 2025 | 100,000 | 100,000 | - | 1.7 | 167,000 | Common Stock |
| Wealthfront Corp | Jason Kilar | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Clover Health Investments Corp (Class A) | Conard Wai | CEO, Counterpart Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 92,181 | 1,274,463 | - | 2.8 | 258,107 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 91,666 | 458,334 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 91,666 | 424,325 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 90,679 | 1,341,853 | - | 2.1 | 189,519 | Class A Common Stock | |
| Whitefiber Inc | Erke Huang | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 88,235 | 88,235 | - | - | Restricted Stock Units | |
| Whitefiber Inc | Erke Huang | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 88,235 | 88,235 | - | - | Ordinary Shares, $.01 par value | |
| Whitefiber Inc | Samir Tabar | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 88,235 | 88,235 | - | - | Restricted Stock Units | |
| Whitefiber Inc | Samir Tabar | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 88,235 | 147,058 | - | - | Ordinary Shares, $.01 par value | |
| Clover Health Investments Corp (Class A) | Brady Patrick Priest | CEO of Home Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 82,778 | 2,388,579 | - | 2.8 | 231,778 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. | 15 Oct 2025 | 80,745 | 2,164,706 | - | 0.2 | 19,379 | Class A Common Stock |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 80,745 | 1,542,974 | - | - | Stock Option (Right to Buy) | |
| Evolv Tech Holdings Inc (Class A) | Michael Philip Ellenbogen | Director | Sale of securities on an exchange or to another person at price $ 8.26 per share. | 15 Oct 2025 | 80,745 | 2,083,961 | - | 8.3 | 666,954 | Class A Common Stock |
| Dell | Ellen J. Kullman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 79,806 | 8,801 | - | - | Options to Acquire Class C Common Stock | |
| Dell | Ellen J. Kullman | Director | Sale of securities on an exchange or to another person at price $ 153.56 per share. | 15 Oct 2025 | 79,806 | 65,662 (0%) | 0% | 153.6 | 12,255,009 | Class C Common Stock |
| Dell | Ellen J. Kullman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.98 per share. | 15 Oct 2025 | 79,806 | 145,468 (0%) | 0% | 14.0 | 1,115,688 | Class C Common Stock |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.10 per share. | 15 Oct 2025 | 76,892 | 31,708 | - | 44.1 | 3,390,937 | Class A Common Stock |
| Sera Prognostics Inc (Class A) | Tiffany Eul Davis Inglis | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 75,000 | 75,000 | - | 0 | Class A Common Stock | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Deputy CFO and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 75,000 | 456,575 (0%) | 0% | - | Common Stock | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Deputy CFO and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 75,000 | 75,000 | - | - | Restricted Stock Units (RSUs) | |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 72,675 | 1,414,528 | - | 0 | Class A Common Stock | ||
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 72,675 | 654,070 | - | - | Restricted Stock Units (RSU) | ||
| Clover Health Investments Corp (Class A) | Jamie L. Reynoso | CEO, Medicare Advantage | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 71,432 | 2,971,740 | - | 2.8 | 200,010 | Class A Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 15 Oct 2025 | 67,575 | 240,771 (0%) | 0% | 7.0 | 473,701 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 65,000 | 478,240 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 65,000 | 325,000 | - | - | Restricted Stock Units (RSU) | |
| Clover Health Investments Corp (Class A) | Karen M. Soares | General Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. | 15 Oct 2025 | 57,249 | 1,405,835 | - | 2.8 | 160,297 | Class A Common Stock |
| Peloton Interactive Inc | Charles Kirol | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 56,510 | 70,862 (0%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Charles Kirol | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 56,510 | 565,100 | - | - | Restricted Stock Unit (RSU) | |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 51,922 | 470,573 | - | 0 | Class A Common Stock | |
| Arlo Tech Inc | Kurtis J. Binder | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.82 per share. | 15 Oct 2025 | 51,668 | 416,013 (0%) | 0% | 17.8 | 920,527 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 139.16 per share. | 15 Oct 2025 | 51,443 | 25,035 | - | 139.2 | 7,158,967 | Class A Common Stock |
| Ribbon Communications Inc | John Townsend | EVP, Chief Financial Officer | 15 Oct 2025 | 50,448 | 77,757 (0%) | 0% | 3.8 | 192,207 | Common Stock | |
| Sutro Biopharma Inc | Connie L. Matsui | Director | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 50,000 | 50,000 (0%) | 0% | 0.8 | 39,950 | Common Stock |
| Energy Vault Holdings Inc | Akshay Ladwa | Chief Operations Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2025 | 50,000 | 1,867,575 | - | 0 | Common Stock | |
| New Horizon Aircraft Ltd (Class A) | Brian Merker | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 15 Oct 2025 | 46,000 | 265,286 | - | 4 | 184,000 | Class A Ordinary Shares, without par value |
| Compass Minerals Intl Inc | Edward C. Dowling | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 45,467 | 65,978 (0%) | 0% | 0 | Common Stock | |
| Compass Minerals Intl Inc | Edward C. Dowling | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 45,467 | 90,933 | - | - | Restricted Stock Unit | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 45,125 | 586,630 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 45,125 | 1,336,563 | - | 0 | Class A Common Stock | |
| Karyopharm Therapeutics Inc | Michael Mano | SVP, General Counsel&Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 43,650 | 65,075 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Lori Macomber | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 43,650 | 54,316 (0%) | 0% | 0 | Common Stock | |
| Karyopharm Therapeutics Inc | Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 43,650 | 79,506 (0%) | 0% | 0 | Common Stock | |
| Copart | Jeffrey Liaw | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 43,166 | 312,391 | - | - | Employee Stock Option (right to buy) | |
| Copart | Jeffrey Liaw | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.70 per share. | 15 Oct 2025 | 43,166 | 55,615 (0%) | 0% | 8.7 | 375,544 | Common Stock |
| Designer Brands Inc (Class A) | Mark A. Haley | SVP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 42,135 | 42,135 | - | - | Restricted Stock Unit | |
| Petco Health and Wellness Co Inc (Class A) | Holly May | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.55 per share. | 15 Oct 2025 | 41,811 | 1,979,577 | - | 3.5 | 148,429 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 40,132 | 384,193 | - | 2.1 | 83,876 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 2.07 per share. | 15 Oct 2025 | 40,000 | 344,193 | - | 2.1 | 82,996 | Class A Common Stock |
| Karyopharm Therapeutics Inc | Stuart Poulton | EVP, Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 39,682 | 67,392 (0%) | 0% | 0 | Common Stock | |
| Pluri Inc | Yaky Yanay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 39,050 | 491,170 (2%) | 0% | 0 | Common Stock | |
| Pluri Inc | Yaky Yanay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 39,050 | 39,050 | - | - | Stock Option | |
| Talphera Inc | Joseph Todisco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 38,381 | 38,381 | - | - | Director Stock Option (right to buy) | |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 36,905 | 1,377,623 | - | 2.1 | 77,131 | Class A Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 138.09 per share. | 15 Oct 2025 | 35,530 | 76,478 | - | 138.1 | 4,906,419 | Class A Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 15 Oct 2025 | 34,732 | 318,030 (4%) | 0% | 22.7 | 789,806 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 33,575 | 1,271,010 | - | 0 | Class A Common Stock | ||
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 33,575 | 33,574 | - | - | Restricted Stock Units (RSU) | ||
| Lexeo Therapeutics Inc | Richard Nolan Townsend | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 33,000 | 255,251 | - | 0 | Common Stock | |
| Lightbridge Corp | Seth Grae | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.60 per share. | 15 Oct 2025 | 32,296 | 785,612 (24%) | 0% | 12.6 | 406,930 | Common Stock |
| Lightbridge Corp | Seth Grae | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.07 per share. | 15 Oct 2025 | 32,296 | 753,316 (23%) | 0% | 28.1 | 906,549 | Common Stock |
| Lightbridge Corp | Seth Grae | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 32,296 | 7,937 | - | - | Employee Stock Option (right to buy) | |
| Gitlab Inc (Class A) | Sytse Sijbrandij | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.75 per share. | 15 Oct 2025 | 31,708 | 0 | - | 44.8 | 1,418,933 | Class A Common Stock |
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | 15 Oct 2025 | 31,256 | 31,256 (0%) | 0% | - | Common Shares | ||
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | 15 Oct 2025 | 31,256 | 0 | - | - | OP Units | ||
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | 15 Oct 2025 | 31,256 | 31,256 | - | - | OP Units | ||
| JBG SMITH Properties | Steven A. Museles | Chief Legal Off. & Corp. Secy | 15 Oct 2025 | 31,256 | 225,535 | - | - | LTIP Units | ||
| Xenon Pharma Inc | Thomas P. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 30,000 | 30,000 | - | - | Restricted Share Units | |
| NextPlat Corp | Hector Delgado | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 30,000 | 54,599 (45%) | 24% | 0 | Common Stock | |
| NextPlat Corp | Anthony Armas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 30,000 | 90,566 (74%) | 24% | 0 | Common Stock | |
| Ribbon Communications Inc | Eric Marmurek | SVP, Deputy CFO and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.81 per share. | 15 Oct 2025 | 29,512 | 427,063 (0%) | 0% | 3.8 | 112,441 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.37 per share. | 15 Oct 2025 | 29,264 | 140,304 | - | 60.4 | 1,766,668 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.31 per share. | 15 Oct 2025 | 28,999 | 147,358 | - | 1.3 | 37,989 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 28,999 | 0 | - | - | Stock Option (Right to Buy) | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 137.32 per share. | 15 Oct 2025 | 28,412 | 112,008 | - | 137.3 | 3,901,502 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 28,146 | 450,094 | - | 2.1 | 58,825 | Class A Common Stock |
| Cipher Mining Inc | Patrick Kelly | Co-President and COO | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 15 Oct 2025 | 26,581 | 1,213,919 | - | 21.1 | 560,327 | Common Stock |
| Kelly Services Inc (Class A) | Troy R. Anderson | Executive Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.40 per share. | 15 Oct 2025 | 25,319 | 175,943 (0%) | 0% | 12.4 | 313,956 | Class A Common Stock, Par Value $1 |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 25,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.10 per share. | 15 Oct 2025 | 25,000 | 308,346 (0%) | 0% | 3.1 | 77,568 | Common Stock |
| Blend Labs Inc (Class A) | Brian Kneafsey | Head of Revenue | 15 Oct 2025 | 25,000 | 687,909 | - | 3.3 | 83,508 | Class A Common Stock | |
| Dream Finders Homes Inc (Class A) | W. Radford Lovett | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.24 per share. | 15 Oct 2025 | 25,000 | 3,940,883 | - | 24.2 | 606,000 | Class A common stock, par value $0.01 per share |
| Serve Robotics Inc | Euan Abraham | Chief Hardware & Mftg Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.49 per share. | 15 Oct 2025 | 25,000 | 275,539 | - | 0.5 | 12,135 | Common Stock |
| Serve Robotics Inc | Euan Abraham | Chief Hardware & Mftg Offcr | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 25,000 | 50,875 | - | - | Stock Option (right to buy) | |
| Serve Robotics Inc | Euan Abraham | Chief Hardware & Mftg Offcr | Sale of securities on an exchange or to another person at price $ 17.99 per share. | 15 Oct 2025 | 25,000 | 250,539 | - | 18.0 | 449,750 | Common Stock |
| Beyond Meat Inc | Ethan Brown | President, Chief Exec. Officer | 15 Oct 2025 | 24,000 | 1,627,218 (2%) | 0% | 0 | Common Stock | ||
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 15 Oct 2025 | 24,000 | 301,315 (0%) | 0% | 19.7 | 472,320 | Common Stock |
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 24,000 | 174,052 | - | - | 2018 Employee Stock Option (right to buy) | |
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 24,000 | 150,052 | - | - | 2018 Employee Stock Option (right to buy) | |
| Vistra | James A. Burke | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.68 per share. | 15 Oct 2025 | 24,000 | 303,952 (0%) | 0% | 19.7 | 472,320 | Common Stock |
| Resources Connection Inc | Kate W. Duchene | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 4.36 per share. | 15 Oct 2025 | 23,015 | 590,233 (1%) | 0% | 4.4 | 100,451 | Common Stock |
| TD Synnex Corp | Patrick Laurent Zammit | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 22,957 | 182,292 (0%) | 0% | 0 | Common Stock | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Oct 2025 | 22,722 | 255,808 (0%) | 0% | 0 | Common Stock | |
| Petco Health and Wellness Co Inc (Class A) | Giovanni Insana | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.55 per share. | 15 Oct 2025 | 22,271 | 445,248 | - | 3.5 | 79,062 | Class A Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 22,210 | 0 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 15 Oct 2025 | 22,210 | 169,568 | - | 2.1 | 46,197 | Common Stock |
| Copart | Jeffrey Liaw | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.79 per share. | 15 Oct 2025 | 22,086 | 31,332 (0%) | 0% | 44.8 | 989,236 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 140.12 per share. | 15 Oct 2025 | 22,012 | 3,023 | - | 140.1 | 3,084,269 | Class A Common Stock |
| Vistra | James A. Burke | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 209.34 per share. | 15 Oct 2025 | 21,363 | 279,952 (0%) | 0% | 209.3 | 4,472,130 | Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.47 per share. | 15 Oct 2025 | 21,250 | 2,696,561 | - | 5.5 | 116,235 | Class A Common Stock |
| ATI Inc | Kimberly A. Fields | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 85.87 per share. | 15 Oct 2025 | 21,153 | 202,668 (0%) | 0% | 85.9 | 1,816,408 | Common Stock, par value $0.10 per share |
| Peloton Interactive Inc | Charles Kirol | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.57 per share. | 15 Oct 2025 | 20,554 | 50,308 (0%) | 0% | 7.6 | 155,672 | Class A Common Stock |
| Aquestive Therapeutics Inc | Carl N. Kraus | Chief Medical Officer | 15 Oct 2025 | 20,272 | 282,475 (0%) | 0% | 7 | 141,904 | Common Stock | |
| Dream Finders Homes Inc (Class A) | W. Radford Lovett | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 23.52 per share. | 15 Oct 2025 | 20,000 | 3,920,883 | - | 23.5 | 470,400 | Class A common stock, par value $0.01 per share |
| Home Federal Bancorp Inc (Louisiana) | James R. Barlow | Director, Chairman, President & CEO*** | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 20,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Home Federal Bancorp Inc (Louisiana) | James R. Barlow | Director, Chairman, President & CEO*** | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 15 Oct 2025 | 20,000 | 114,483 (6%) | 1% | 11.5 | 230,000 | Common Stock |
| Home Federal Bancorp Inc (Louisiana) | James R. Barlow | Director, Chairman, President & CEO*** | Sale or transfer of securities back to the company at price $ 14.20 per share. | 15 Oct 2025 | 20,000 | 94,483 (5%) | 1% | 14.2 | 284,000 | Common Stock |
| NextPlat Corp | Douglas S. Ellenoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 20,000 | 145,000 (119%) | 16% | 0 | Common Stock | |
| Sutro Biopharma Inc | Gregory K. Chow | CFO | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 15 Oct 2025 | 19,750 | 19,750 (0%) | 0% | 0.8 | 15,998 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 19,707 | 341,287 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 19,707 | 39,414 | - | - | Restricted Stock Units (RSU) | |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 77.16 per share. | 15 Oct 2025 | 19,542 | 481,079 | - | 77.2 | 1,507,861 | Common Stock |
| Vistra | James A. Burke | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 215.06 per share. | 15 Oct 2025 | 19,200 | 284,752 (0%) | 0% | 215.1 | 4,129,152 | Common Stock |
| QuidelOrtho Corporation | Jonathan Philip Siegrist | EVP of R&D & CTO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 18,656 | 37,314 | - | - | Restricted Stock Units | |
| QuidelOrtho Corporation | Jonathan Philip Siegrist | EVP of R&D & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 18,656 | 18,656 (0%) | 0% | 0 | Common Stock | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 18,000 | 1,423,255 | - | - | Stock Option (Right to Buy) | |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 18,000 | 512,104 | - | 0 | Class A Common Stock | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Sale or transfer of securities back to the company at price $ 52.28 per share. | 15 Oct 2025 | 17,892 | 2,651,313 (0%) | 0% | 52.3 | 935,394 | Common Stock |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 17,892 | 2,669,205 (0%) | 0% | - | Common Stock | |
| Bank of America | Brian T. Moynihan | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 17,892 | 71,566 | - | - | 2025 Cash Settled Restricted Stock Units | |
| Nextdoor Holdings Inc (Class A) | Nirav Tolia | Director, CEO and President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 17,757 | 1,318,806 | - | 2.1 | 37,112 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.27 per share. | 15 Oct 2025 | 17,204 | 2,668,146 | - | 5.3 | 90,583 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Craig Lisowski | President of Products | 15 Oct 2025 | 17,050 | 1,253,960 | - | 2.1 | 35,635 | Class A Common Stock | |
| Sutro Biopharma Inc | Hans-Peter Gerber | CHIEF SCIENTIFIC OFFICER | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 17,000 | 71,832 (0%) | 0% | 0.8 | 13,607 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,915 | 420,564 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,915 | 33,830 | - | - | Restricted Stock Units (RSU) | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.19 per share. | 15 Oct 2025 | 16,800 | 1,731,305 (0%) | 0% | 34.2 | 574,392 | Common Stock |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,800 | 17,108 | - | - | Stock Option Grant | |
| QUALCOMM | Cristiano R. Amon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,715 | 166,019 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Cristiano R. Amon | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,715 | 39,253 | - | - | Restricted Stock Unit | |
| GrabAGun Digital Holdings Inc | Marc Nemati | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,667 | 183,333 | - | - | Restricted Stock Units | |
| GrabAGun Digital Holdings Inc | Marc Nemati | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,667 | 2,516,667 | - | - | Common Stock | |
| Apple | Kevan Parekh | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 16,457 | 21,026 (0%) | 0% | - | Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 15 Oct 2025 | 15,633 | 44,586 | - | 2.0 | 31,355 | Class A Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 89.98 per share. | 15 Oct 2025 | 15,624 | 49,086 | - | 90.0 | 1,405,848 | Class A Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 15,624 | 157,984 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 15 Oct 2025 | 15,624 | 64,710 | - | 6.9 | 107,649 | Class A Common Stock |
| Compass Minerals Intl Inc | Edward C. Dowling | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.53 per share. | 15 Oct 2025 | 15,189 | 50,789 (0%) | 0% | 19.5 | 296,641 | Common Stock |
| Ethan Allen Interiors Inc | M. Farooq Kathwari | Director, Chairman, President & CEO | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 15 Oct 2025 | 15,000 | 1,583,652 (6%) | 0% | 28.0 | 420,150 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.72 per share. | 15 Oct 2025 | 14,896 | 116,445 | - | 62.7 | 934,326 | Common Stock |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 15 Oct 2025 | 14,775 | 562,118 | - | 6.1 | 90,275 | Common Stock |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 14,775 | 163,367 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 31.11 per share. | 15 Oct 2025 | 14,775 | 547,343 | - | 31.1 | 459,662 | Common Stock |
| Remitly Global Inc | Matthew Oppenheimer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.59 per share. | 15 Oct 2025 | 14,583 | 4,515,188 | - | 15.6 | 227,349 | Common Stock |
| Remitly Global Inc | Matthew Oppenheimer | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.39 per share. | 15 Oct 2025 | 14,583 | 4,500,605 | - | 15.4 | 224,432 | Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 90.04 per share. | 15 Oct 2025 | 14,205 | 65,963 | - | 90.0 | 1,279,018 | Class A Common Stock |
| Monolithic Power | Saria Tseng | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 1016.18 per share. | 15 Oct 2025 | 14,028 | 130,466 (0%) | 0% | 1016.2 | 14,254,973 | Common Stock |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | 15 Oct 2025 | 14,010 | 15,816 (0%) | 0% | 61.2 | 858,070 | Common Stock | |
| Home Federal Bancorp Inc (Louisiana) | Mary L. Jones | Sr. VP Retail & COO* | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 14,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Home Federal Bancorp Inc (Louisiana) | Mary L. Jones | Sr. VP Retail & COO* | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 15 Oct 2025 | 14,000 | 23,060 (1%) | 0% | 11.5 | 161,000 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 88.91 per share. | 15 Oct 2025 | 13,014 | 398,345 | - | 88.9 | 1,157,075 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 88.91 per share. | 15 Oct 2025 | 13,014 | 454,831 | - | 88.9 | 1,157,075 | Common Stock |
| Standex Intl Corp | David A. Dunbar | Director, President/CEO/Chairman | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 15 Oct 2025 | 13,000 | 103,973 (0%) | 0% | 235 | 3,055,000 | Common Stock |
| Home Federal Bancorp Inc (Louisiana) | Thomas Steen Trawick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.50 per share. | 15 Oct 2025 | 13,000 | 27,558 (1%) | 0% | 11.5 | 149,500 | Common Stock |
| Home Federal Bancorp Inc (Louisiana) | Thomas Steen Trawick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Lexeo Therapeutics Inc | Richard Nolan Townsend | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 8.94 per share. | 15 Oct 2025 | 12,985 | 242,266 | - | 8.9 | 116,021 | Common Stock |
| Karyopharm Therapeutics Inc | Kristin Abate | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 12,799 | 22,845 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | David Pauling | Chief Admin. Ofcr. & GC | 15 Oct 2025 | 12,504 | 71,737 (0%) | 0% | 0.8 | 9,993 | Common Stock | |
| Sutro Biopharma Inc | Jane Chung | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 15 Oct 2025 | 12,500 | 122,850 (0%) | 0% | 0.8 | 10,011 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 12,376 | 145,608 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 15 Oct 2025 | 12,376 | 61,462 | - | 6.9 | 85,271 | Class A Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 136.23 per share. | 15 Oct 2025 | 11,759 | 140,420 | - | 136.2 | 1,601,964 | Class A Common Stock |
| Cricut Inc (Class A) | Ashish Arora | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.27 per share. | 15 Oct 2025 | 11,211 | 2,685,350 | - | 5.3 | 59,044 | Class A Common Stock |
| Lexeo Therapeutics Inc | Sandi See Tai | Chief Development Officer | 15 Oct 2025 | 10,890 | 69,750 | - | 0 | Common Stock | ||
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 250.56 per share. | 15 Oct 2025 | 10,740 | 2,379,198 (0%) | 0% | 250.6 | 2,691,014 | Class C Capital Stock |
| Zscaler Inc | Michael J. Rich | CRO and President of WW Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 10,730 | 111,552 (0%) | 0% | 0 | Commom Stock | |
| Zscaler Inc | Adam Geller | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 10,730 | 54,208 (0%) | 0% | 0 | Commom Stock | |
| Home Federal Bancorp Inc (Louisiana) | Thomas Steen Trawick | Director | Sale or transfer of securities back to the company at price $ 14.20 per share. | 15 Oct 2025 | 10,529 | 17,029 (0%) | 0% | 14.2 | 149,512 | Common Stock |
| Northwest Natural Holding Co | David H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 15 Oct 2025 | 10,509 | 51,922 (0%) | 0% | 45.0 | 472,912 | Common Stock |
| Mineralys Therapeutics Inc | David Rodman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.01 per share. | 15 Oct 2025 | 10,369 | 71,155 | - | 43.0 | 445,982 | Common Stock |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 10,225 | 153,142 | - | - | Non-Qualified Stock Option (right to buy) | |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 31.46 per share. | 15 Oct 2025 | 10,225 | 547,343 | - | 31.5 | 321,691 | Common Stock |
| Sionna Therapeutics Inc | Michael Cloonan | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 15 Oct 2025 | 10,225 | 557,568 | - | 6.1 | 62,475 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 90.66 per share. | 15 Oct 2025 | 10,095 | 385,999 | - | 90.7 | 915,213 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 90.66 per share. | 15 Oct 2025 | 10,094 | 442,486 | - | 90.7 | 915,122 | Common Stock |
| Home Federal Bancorp Inc (Louisiana) | Mary L. Jones | Sr. VP Retail & COO* | Sale or transfer of securities back to the company at price $ 14.20 per share. | 15 Oct 2025 | 10,005 | 13,055 (0%) | 0% | 14.2 | 142,071 | Common Stock |
| Yelp Inc | David A. Schwarzbach | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 33.58 per share. | 15 Oct 2025 | 10,000 | 160,196 (0%) | 0% | 33.6 | 335,785 | Common Stock |
| Aquestive Therapeutics Inc | Peter Boyd | See Remarks | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 15 Oct 2025 | 10,000 | 268,323 (0%) | 0% | 7 | 70,000 | Common Stock |
| Chicago Atlantic Real Estate Finance Inc | Jason D. Papastavrou | Director | Purchase of securities on an exchange or from another person at price $ 12.62 per share. | 15 Oct 2025 | 10,000 | 49,546 | - | 12.6 | 126,150 | Common Stock |
| Argan Inc | Peter W. Getsinger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 10,000 | 21,500 | - | - | Option to Purchase Common Stock | |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Sale of securities on an exchange or to another person at price $ 309.37 per share. | 15 Oct 2025 | 10,000 | 21,006 (0%) | 0% | 309.4 | 3,093,700 | Common Stock |
| AMKOR Tech Inc | Guillaume Marie Jean Rutten | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 30.74 per share. | 15 Oct 2025 | 10,000 | 356,699 (0%) | 0% | 30.7 | 307,400 | Common Stock |
| Amplitude Inc (Class A) | Erica Ruliffson Schultz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 10,000 | 69,500 | - | - | Stock Option (Right to Buy) | |
| Amplitude Inc (Class A) | Erica Ruliffson Schultz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.19 per share. | 15 Oct 2025 | 10,000 | 117,406 | - | 4.2 | 41,900 | Class A Common Stock |
| Amplitude Inc (Class A) | Erica Ruliffson Schultz | Director | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 15 Oct 2025 | 10,000 | 107,406 | - | 10.1 | 101,229 | Class A Common Stock |
| Angi Inc (Class A) | Bailey Carson | Chief Operating Officer | 15 Oct 2025 | 10,000 | 30,000 | - | - | Restricted Stock Units | ||
| Angi Inc (Class A) | Bailey Carson | Chief Operating Officer | 15 Oct 2025 | 10,000 | 23,166 (0%) | 0% | - | Class A Common Stock, par value $0.001 | ||
| Angi Inc (Class A) | Glenn Orchard | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 10,000 | 30,000 | - | - | Restricted Stock Units | |
| Angi Inc (Class A) | Glenn Orchard | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 10,000 | 13,973 (0%) | 0% | - | Class A Common Stock, par value $0.001 | |
| StandardAero Inc | Alexander Trapp | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 29.21 per share. | 15 Oct 2025 | 10,000 | 0 | - | 29.2 | 292,100 | Common Stock |
| Lexeo Therapeutics Inc | Jenny R. Robertson | Chief Legal Officer | 15 Oct 2025 | 9,900 | 72,456 | - | 0 | Common Stock | ||
| JBG SMITH Properties | Evan Regan-Levine | Chief Strategy Officer | 15 Oct 2025 | 9,685 | 9,685 (0%) | 0% | - | Common Shares | ||
| JBG SMITH Properties | Evan Regan-Levine | Chief Strategy Officer | 15 Oct 2025 | 9,685 | 584 | - | - | OP Units | ||
| JBG SMITH Properties | Evan Regan-Levine | Chief Strategy Officer | 15 Oct 2025 | 9,685 | 10,269 | - | - | OP Units | ||
| JBG SMITH Properties | Evan Regan-Levine | Chief Strategy Officer | 15 Oct 2025 | 9,685 | 123,326 | - | - | LTIP Units | ||
| Lexeo Therapeutics Inc | Eric Adler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 9,570 | 76,643 | - | 0 | Common Stock | |
| Globalstar Inc | Rebecca S. Clary | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 9,524 | 115,185 (0%) | 0% | 0 | Voting Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 9,478 | 104,266 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 9,478 | 63,617 | - | 0 | Class A Common Stock | |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 9,330 | 9,331 | - | - | Restricted Stock Units | |
| AMN Healthcare Services Inc | Mark Christopher Hagan | Chief Information and Digital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 9,330 | 42,038 (0%) | 0% | 0 | Common Stock | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.53 per share. | 15 Oct 2025 | 9,000 | 73,740 (0%) | 0% | 31.5 | 283,776 | Ordinary Shares |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.49 per share. | 15 Oct 2025 | 8,963 | 131,341 | - | 61.5 | 551,161 | Common Stock |
| Ribbon Communications Inc | Bruns H. Grayson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 8,881 | 755,710 (0%) | 0% | - | Common Stock | |
| GRAIL Inc | Josh Ofman | President | Sale of securities on an exchange or to another person at price $ 76.03 per share. | 15 Oct 2025 | 8,865 | 387,932 | - | 76.0 | 673,985 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Sophia Schwartz | General Counsel and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 8,628 | 332,659 | - | 2.1 | 18,033 | Class A Common Stock |
| PayPal | Diego Scotti | EVP, GM Consumer Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,588 | 25,577 (0%) | 0% | 0 | Common Stock | |
| PayPal | Diego Scotti | EVP, GM Consumer Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,588 | 42,939 | - | - | Restricted Stock Units -1 | |
| Argan Inc | Peter W. Getsinger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.35 per share. | 15 Oct 2025 | 8,493 | 20,389 (0%) | 0% | 46.4 | 393,651 | Common Stock |
| Leonardo DRS Inc | John A. Baylouny | EVP and COO | Sale of securities on an exchange or to another person at price $ 43.69 per share. | 15 Oct 2025 | 8,481 | 106,007 | - | 43.7 | 370,535 | Common Stock |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,409 | 282,958 (0%) | 0% | 0 | Common Stock | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,409 | 84,087 | - | - | Restricted Stock Units | |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 251.40 per share. | 15 Oct 2025 | 8,401 | 2,370,797 (0%) | 0% | 251.4 | 2,112,011 | Class C Capital Stock |
| GrabAGun Digital Holdings Inc | Matthew Vittitow | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 2,516,666 | - | - | Common Stock | |
| GrabAGun Digital Holdings Inc | Matthew Vittitow | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 2,508,333 | - | - | Common Stock | |
| GrabAGun Digital Holdings Inc | Matthew Vittitow | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 83,334 | - | - | Restricted Stock Units | |
| GrabAGun Digital Holdings Inc | Matthew Vittitow | Director, Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 91,667 | - | - | Restricted Stock Units | |
| GrabAGun Digital Holdings Inc | Justin C. Hilty | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 16,666 | - | - | Common Stock | |
| GrabAGun Digital Holdings Inc | Justin C. Hilty | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 8,333 | - | - | Common Stock | |
| GrabAGun Digital Holdings Inc | Justin C. Hilty | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 83,334 | - | - | Restricted Stock Units | |
| GrabAGun Digital Holdings Inc | Justin C. Hilty | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,333 | 91,667 | - | - | Restricted Stock Units | |
| QUALCOMM | Akash J. Palkhiwala | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,111 | 47,985 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Akash J. Palkhiwala | CFO & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,111 | 16,223 | - | - | Restricted Stock Unit | |
| Apple | Kevan Parekh | Senior Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 249.34 per share. | 15 Oct 2025 | 8,062 | 12,964 (0%) | 0% | 249.3 | 2,010,179 | Common Stock |
| Bicara Therapeutics Inc | Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 15 Oct 2025 | 8,000 | 202,641 | - | 18.2 | 145,243 | Common Stock |
| Bicara Therapeutics Inc | Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. | 15 Oct 2025 | 8,000 | 210,641 | - | 3.8 | 30,318 | Common Stock |
| Bicara Therapeutics Inc | Ryan Cohlhepp | Director, President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 8,000 | 157,334 | - | - | Stock Option (Right to Buy) | |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,882 | 407,062 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,882 | 15,764 | - | - | Restricted Stock Units (RSU) | |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 15 Oct 2025 | 7,495 | 77,126 | - | 27.9 | 208,736 | Class A Common Stock |
| Nuvalent Inc (Class A) | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,495 | 13,156 | - | - | Stock Option (Right to Buy) | |
| TruBridge Inc | Michael Daughton | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 7,492 | 7,492 (0%) | 0% | 0 | Common Stock | |
| Rapport Therapeutics Inc | David Bredt | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.73 per share. | 15 Oct 2025 | 7,418 | 410,724 | - | 25.7 | 190,887 | Common Stock |
| Compass Minerals Intl Inc | Benjamin S. Nichols | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,408 | 15,389 (0%) | 0% | 0 | Common Stock | |
| Apple | Chris Kondo | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,371 | 22,469 (0%) | 0% | - | Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,346 | 52,061 | - | 0 | Class A Common Stock | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,346 | 73,464 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,346 | 44,079 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,346 | 56,773 | - | 0 | Class A Common Stock | |
| QUALCOMM | Cristiano R. Amon | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.97 per share. | 15 Oct 2025 | 7,331 | 158,688 (0%) | 0% | 163.0 | 1,194,733 | Common Stock |
| Nextdoor Holdings Inc (Class A) | Michael Kiernan | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.09 per share. | 15 Oct 2025 | 7,324 | 413,240 | - | 2.1 | 15,307 | Class A Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.88 per share. | 15 Oct 2025 | 7,239 | 727,388 | - | 68.9 | 498,622 | Common Stock |
| Ribbon Communications Inc | Shaul Shani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 7,236 | 160,947 (0%) | 0% | - | Common Stock | |
| Antero Resources Corp | Michael N. Kennedy | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.14 per share. | 15 Oct 2025 | 7,165 | 1,179,075 (0%) | 0% | 32.1 | 230,283 | Common stock, par value $0.01 per share |
| Zscaler Inc | Robert S. Schlossman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 7,154 | 83,286 (0%) | 0% | 0 | Common Stock | |
| Whitefiber Inc | Ichi Shih | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 7,059 | 7,059 | - | - | Ordinary Shares, $.01 par value | |
| Whitefiber Inc | Ichi Shih | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 7,058 | 7,058 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,969 | 41,812 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,969 | 278,219 (0%) | 0% | 0 | Common Stock | |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | 15 Oct 2025 | 6,940 | 6,940 | - | - | Employee Stock Option (right to buy) | ||
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | 15 Oct 2025 | 6,940 | 22,756 (0%) | 0% | 50.5 | 350,609 | Common Stock | |
| CIENA Corp | Gary B. Smith | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 170.25 per share. | 15 Oct 2025 | 6,800 | 275,270 (0%) | 0% | 170.3 | 1,157,706 | Common Stock |
| QuidelOrtho Corporation | Jonathan Philip Siegrist | EVP of R&D & CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.31 per share. | 15 Oct 2025 | 6,676 | 11,980 (0%) | 0% | 27.3 | 182,322 | Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 199.97 per share. | 15 Oct 2025 | 6,623 | 504,481 | - | 200.0 | 1,324,401 | Class A Common Stock |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,568 | 13,137 | - | - | Restricted Stock Units (RSU) | |
| Nextdoor Holdings Inc (Class A) | Antoinette How | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,568 | 45,074 | - | 0 | Class A Common Stock | |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.09 per share. | 15 Oct 2025 | 6,453 | 109,992 | - | 63.1 | 407,099 | Common Stock |
| Reddit Inc (Class A) | Steve Huffman | Director, CEO & President, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 200.81 per share. | 15 Oct 2025 | 6,436 | 498,045 | - | 200.8 | 1,292,413 | Class A Common Stock |
| Talphera Inc | Joseph Todisco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 6,397 | 6,397 (0%) | 0% | 0 | Common Stock | |
| Identiv Inc | Kristen F. Newquist | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.45 per share. | 15 Oct 2025 | 6,348 | 220,845 (1%) | 0% | 3.5 | 21,901 | Common Stock |
| Palomar Holdings Inc | Mac Armstrong | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,250 | 18,750 | - | - | Restricted Stock Units (RSUs) | |
| Palomar Holdings Inc | Mac Armstrong | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,250 | 79,592 (0%) | 0% | 0 | Common Stock (RSUs) | |
| Flagstar Fin Inc | George F. Buchanan | EVP and Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Oct 2025 | 6,198 | 99,069 (0%) | 0% | 0 | Common Stock | |
| GRAIL Inc | Josh Ofman | President | Sale of securities on an exchange or to another person at price $ 82.01 per share. | 15 Oct 2025 | 6,114 | 381,818 | - | 82.0 | 501,409 | Common Stock |
| Compass Minerals Intl Inc | Benjamin S. Nichols | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,089 | 12,179 | - | - | Restricted Stock Unit | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | General Counsel | Sale of securities on an exchange or to another person at price $ 22.41 per share. | 15 Oct 2025 | 6,000 | 105,386 | - | 22.4 | 134,439 | Ordinary Shares |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,000 | 227,559 | - | - | Share Option (right to buy) | |
| Centessa Pharma PLC (ADR) | Iqbal Hussain | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.84 per share. | 15 Oct 2025 | 6,000 | 111,386 | - | 5.8 | 35,040 | Ordinary Shares |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.51 per share. | 15 Oct 2025 | 6,000 | 21,937 (0%) | 0% | 48.5 | 291,060 | Common Stock |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 6,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ionis Pharma Inc | Shannon L. Devers | EVP, Chief Human Resources Ofc | Sale of securities on an exchange or to another person at price $ 72.94 per share. | 15 Oct 2025 | 6,000 | 15,937 (0%) | 0% | 72.9 | 437,654 | Common Stock |
| Lexeo Therapeutics Inc | Jose Manuel Otero | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,940 | 66,312 | - | 0 | Common Stock | |
| PayPal | Aaron J. Webster | EVP, Global Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,901 | 46,241 (0%) | 0% | 0 | Common Stock | |
| PayPal | Aaron J. Webster | EVP, Global Chief Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,901 | 35,401 | - | - | Restricted Stock Units -1 | |
| Equitable Holdings Inc | Jeffrey J. Hurd | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 48.86 per share. | 15 Oct 2025 | 5,883 | 76,004 (0%) | 0% | 48.9 | 287,448 | Common Stock |
| Apple | Kevan Parekh | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,816 | 11,633 | - | - | Restricted Stock Unit | |
| TD Synnex Corp | David R. Vetter | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,739 | 69,440 (0%) | 0% | 0 | Common Stock | |
| TD Synnex Corp | Dennis J. Polk | Director, Hyve Solutions Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,739 | 34,099 (0%) | 0% | 0 | Common Stock | |
| TD Synnex Corp | David Gregory Jordan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,739 | 17,945 (0%) | 0% | 0 | Common Stock | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Sale of securities on an exchange or to another person at price $ 224.51 per share. | 15 Oct 2025 | 5,695 | 1,720,221 (0%) | 0% | 224.5 | 1,278,584 | Common Stock |
| TD Synnex Corp | Reyna Thompson | President, North America | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,548 | 16,805 (0%) | 0% | 0 | Common Stock | |
| Apple | Kevan Parekh | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,530 | 0 | - | - | Restricted Stock Unit | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,519 | 22,077 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,519 | 274,156 (0%) | 0% | 0 | Common Stock | |
| AMD | Mark D. Papermaster | Chief Technology Officer & EVP | Sale of securities on an exchange or to another person at price $ 225.59 per share. | 15 Oct 2025 | 5,516 | 1,714,705 (0%) | 0% | 225.6 | 1,244,354 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.41 per share. | 15 Oct 2025 | 5,513 | 2,394,559 (0%) | 0% | 248.4 | 1,369,484 | Class C Capital Stock |
| Antero Resources Corp | Yvette K. Schultz | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.14 per share. | 15 Oct 2025 | 5,512 | 301,307 (0%) | 0% | 32.1 | 177,156 | Common stock, par value $0.01 per share |
| QUALCOMM | Ann C. Chaplin | General Counsel&Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,475 | 10,950 | - | - | Restricted Stock Unit | |
| QUALCOMM | Ann C. Chaplin | General Counsel&Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,475 | 20,161 (0%) | 0% | 0 | Common Stock | |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,235 | 19,500 | - | - | Option to Purchase Common Stock | |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.31 per share. | 15 Oct 2025 | 5,235 | 26,241 (0%) | 0% | 42.3 | 221,493 | Common Stock |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 91.37 per share. | 15 Oct 2025 | 5,199 | 53,986 | - | 91.4 | 475,033 | Class A Common Stock |
| TD Synnex Corp | Alim Dhanji | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 5,165 | 15,188 (0%) | 0% | 0 | Common Stock | |
| Apple | Kevan Parekh | Senior Vice President, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,111 | 20,442 | - | - | Restricted Stock Unit | |
| QUALCOMM | Alexander H. Rogers | President QTL & Global Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,086 | 25,942 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Alexander H. Rogers | President QTL & Global Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,086 | 11,947 | - | - | Restricted Stock Unit | |
| QUALCOMM | Heather S. Ace | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,069 | 18,265 (0%) | 0% | 0 | Common Stock | |
| QUALCOMM | Heather S. Ace | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,069 | 10,140 | - | - | Restricted Stock Unit | |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 87.37 per share. | 15 Oct 2025 | 5,066 | 467,845 | - | 87.4 | 442,616 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 87.37 per share. | 15 Oct 2025 | 5,065 | 411,359 | - | 87.4 | 442,529 | Common Stock |
| Marqeta Inc (Class A) | Crystal Sumner | See Remarks | Sale of securities on an exchange or to another person at price $ 4.79 per share. | 15 Oct 2025 | 5,056 | 277,698 | - | 4.8 | 24,234 | Class A Common Stock |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 5,000 | 45,104 | - | - | Employee Stock Option (Right to Buy) | |
| Alkermes PLC | Craig C. Hopkinson | EVP R&D, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.34 per share. | 15 Oct 2025 | 5,000 | 82,740 (0%) | 0% | 19.3 | 96,700 | Ordinary Shares |
| Ionis Pharma Inc | B. Lynne Parshall | Director | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 15 Oct 2025 | 5,000 | 61,344 (0%) | 0% | 71.7 | 358,722 | Common Stock |
| Chicago Atlantic Real Estate Finance Inc | Jason D. Papastavrou | Director | Purchase of securities on an exchange or from another person at price $ 12.71 per share. | 15 Oct 2025 | 5,000 | 5,000 | - | 12.7 | 63,550 | Common Stock |
| Standex Intl Corp | David A. Dunbar | Director, President/CEO/Chairman | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 15 Oct 2025 | 5,000 | 116,973 (0%) | 0% | 235 | 1,175,000 | Common Stock |
| Emergent Biosolutions Inc | Richard S. Lindahl | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.60 per share. | 15 Oct 2025 | 4,995 | 291,497 (0%) | 0% | 9.6 | 47,952 | Common Stock |
| AMN Healthcare Services Inc | Whitney M. Laughlin | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,976 | 21,708 (0%) | 0% | 0 | Common Stock | |
| AMN Healthcare Services Inc | Whitney M. Laughlin | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,976 | 4,976 | - | - | Restricted Stock Units | |
| Nuvalent Inc (Class A) | Deborah Miller | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 92.50 per share. | 15 Oct 2025 | 4,900 | 49,086 | - | 92.5 | 453,250 | Class A Common Stock |
| TD Synnex Corp | Miriam Anne Murphy | President, Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2025 | 4,782 | 18,202 (0%) | 0% | 0 | Common Stock | |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,765 | 14,735 | - | - | Option to Purchase Common Stock | |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.81 per share. | 15 Oct 2025 | 4,765 | 31,006 (0%) | 0% | 33.8 | 161,105 | Common Stock |
| PayPal | Diego Scotti | EVP, GM Consumer Group | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.15 per share. | 15 Oct 2025 | 4,750 | 20,827 (0%) | 0% | 69.2 | 328,463 | Common Stock |
| Angi Inc (Class A) | Glenn Orchard | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.08 per share. | 15 Oct 2025 | 4,701 | 9,272 (0%) | 0% | 14.1 | 66,190 | Class A Common Stock, par value $0.001 |
| Rapport Therapeutics Inc | Abraham N. Ceesay | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.72 per share. | 15 Oct 2025 | 4,647 | 580,765 | - | 25.7 | 119,539 | Common Stock |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 249.61 per share. | 15 Oct 2025 | 4,621 | 2,389,938 (0%) | 0% | 249.6 | 1,153,448 | Class C Capital Stock |
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | 15 Oct 2025 | 4,540 | 4,540 | - | - | Employee Stock Option (right to buy) | ||
| Delta Air Lines | William Charles Carroll | SVP, Fin & Controller | 15 Oct 2025 | 4,540 | 29,826 (0%) | 0% | 39.8 | 180,601 | Common Stock | |
| Copart | Jeffrey Liaw | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,523 | 16,809 | - | - | Employee Stock Option (right to buy) | |
| Copart | Jeffrey Liaw | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.78 per share. | 15 Oct 2025 | 4,523 | 12,449 (0%) | 0% | 6.8 | 30,666 | Common Stock |
| Bicara Therapeutics Inc | Ryan Cohlhepp | Director, President and COO | Sale of securities on an exchange or to another person at price $ 18.16 per share. | 15 Oct 2025 | 4,500 | 198,141 | - | 18.2 | 81,699 | Common Stock |
| Marvell Tech Inc | Chris Koopmans | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,497 | 8,995 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Chris Koopmans | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,497 | 109,322 (0%) | 0% | 0 | Common Stock | |
| Sunrun Inc | Jeanna Steele | Chief Legal & People Officer | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 15 Oct 2025 | 4,475 | 361,789 (0%) | 0% | 21.7 | 97,148 | Common Stock |
| Marvell Tech Inc | Matthew J. Murphy | Director, Chairman of the Board and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.89 per share. | 15 Oct 2025 | 4,428 | 278,530 (0%) | 0% | 88.9 | 393,605 | Common Stock |
| Antero Resources Corp | Brendan E. Krueger | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.14 per share. | 15 Oct 2025 | 4,410 | 290,917 (0%) | 0% | 32.1 | 141,737 | Common stock, par value $0.01 per share |
| Globalstar Inc | Rebecca S. Clary | VP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 44.43 per share. | 15 Oct 2025 | 4,333 | 110,852 (0%) | 0% | 44.4 | 192,525 | Voting Common Stock |
| Rapport Therapeutics Inc | Abraham N. Ceesay | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 25.75 per share. | 15 Oct 2025 | 4,328 | 41,816 | - | 25.7 | 111,429 | Common Stock |
| Marvell Tech Inc | Chris Koopmans | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,077 | 40,770 | - | - | Restricted Stock Units | |
| Marvell Tech Inc | Chris Koopmans | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 4,077 | 112,574 (0%) | 0% | 0 | Common Stock | |
| TD Synnex Corp | Patrick Laurent Zammit | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.81 per share. | 15 Oct 2025 | 4,048 | 159,335 (0%) | 0% | 156.8 | 634,767 | Common Stock |
| Winnebago Ind Inc | Michael J. Happe | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.12 per share. | 15 Oct 2025 | 4,022 | 344,606 (1%) | 0% | 30.1 | 121,143 | Common Stock, $.50 par value |
| Educational Development Corp | Amy Emerson | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 15 Oct 2025 | 4,000 | 6,000 (0%) | 0% | 1.3 | 5,040 | Common Stock |
| JBG SMITH Properties | George Laucks Xanders | Chief Investment Officer | 15 Oct 2025 | 4,000 | 4,000 (0%) | 0% | - | Common Shares | ||
| JBG SMITH Properties | George Laucks Xanders | Chief Investment Officer | 15 Oct 2025 | 4,000 | 4,800 | - | - | OP Units | ||
| JBG SMITH Properties | George Laucks Xanders | Chief Investment Officer | 15 Oct 2025 | 4,000 | 8,800 | - | - | OP Units | ||
| JBG SMITH Properties | George Laucks Xanders | Chief Investment Officer | 15 Oct 2025 | 4,000 | 536,436 | - | - | LTIP Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.